期刊文献+

甲状腺功能紊乱女性患者治疗前后血清leptin和ghrelin水平的变化 被引量:7

Changes of serum leptin and ghrelin levels in dysthyroid women before and after treatment
下载PDF
导出
摘要 目的探讨女性甲状腺功能紊乱患者治疗前、后血清leptin和ghrelin水平的变化。方法选择治疗前、后体脂稳定的21例初诊甲状腺功能亢进(甲亢)和17例甲状腺功能减退(甲减)女性患者,放射免疫分析法测定治疗前、后空腹血清leptin、ghrelin及甲状腺功能,计算体质量指数(BMI)和体脂百分数(%Fat),对照20例。结果 1.甲亢组治疗前空腹血清ghrelin水平(989.0±170.0)ng/L,明显低于对照组(1 205.0±338.0)ng/L(P<0.05);治疗后空腹血清ghrelin水平(1 236.0±179.0)ng/L,明显高于治疗前(P<0.01),且与对照组比较差异无统计学意义(P>0.05)。2.甲减组治疗前空腹血清ghrelin水平(1 537.0±251.0)ng/L明显高于正常对照组(1 205.0±338.0)ng/L(P<0.01),治疗后空腹血清ghrelin水平(1 253.0±370.0)ng/L明显低于治疗前(P<0.05),与对照组比较差异无统计学意义(P>0.05)。3.甲亢组和甲减组空腹leptin水平,治疗前、后与对照组比较差异无统计学意义。结论去除体脂因素后,提示BMI、%Fat并不是影响甲亢和甲减组治疗前空腹ghrelin及leptin水平变化的重要因素,且ghrelin可能参与了甲亢和甲减的发生、发展。 Objective To investigate the changes of serum leptin and ghrelin levels in dysthyroid women before and after treatment.Methods Leptin and ghrelin levels were determined by RIA in 21 cases of hyperthyroid and 17 cases of hypothyroid women with stable body mass index before and after the treatment,then the body mass index(BMI),and percentage of body fat(%Fat)were calculated,20 comparable healthy adult served as control subjects.Results(1)In hyperthyroidism group,before treatment,serum ghrelin levels were lower(989.0±170.0)ng/L(P0.05)than those of the control subjects;after treatment,serum ghrelin levels increased(1 236.0±179.0)ng/L(P0.01) compared with those of the before treatmentand were similar to those in its control subjects(P 0.05).(2) Serum ghrelin levels(1 537.0±251.0)ng/L in patients with hypothyroidism were higher than those of the control group(1 205.0±338.0)ng/L(P0.01)before treatment.After treatment,serum ghrelin levels significantly decreased(1 253.0±370.0)ng/L(P0.05) and had no significant difference compared to control group.3.Serum leptin concentrations in patients with hyperthyroidism or hypothyroidism were similar to those of control group before and after the treatment of hyperthyroidism or hypothyroidism.Conclusion Serum leptin and ghrelin levels is not associated with changes in BMI or %BF,ghrelin might play an important role in the pathogenesis and progress of hyperthyroidism or hypothyroidism before treatment.
出处 《重庆医学》 CAS CSCD 北大核心 2011年第23期2303-2304,2307,共3页 Chongqing medicine
关键词 甲状腺功能亢进症 甲状腺功能减退症 瘦素 胃促生长素 hyperthyroidism hypothyroidism leptin ghrelin
  • 相关文献

参考文献3

二级参考文献19

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2Gimenez-Palop O,Gimenez-Perez G,Mauricio D,et al.Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger,food intake or anthropometric changes.Eur J Endocrinol,2005,153:73-79.
  • 3Shiiya T,Nakazato M,Mizuta M,et al.Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.J Clin Endocrinol Metab,2002,87:240-244.
  • 4Kojima M,Hosoda H,Date Y,et al.Ghrelin is a growthhormone-releasing acylated peptide from stomach.Nature,1999,402:656-660.
  • 5Tschop M,Weyer C,Tataranni PA,et al.Circulating ghrelin levels are decreased in human obesity.Diabetes,2001,50:707-709.
  • 6Nedvidkova J,Krykorkova I,BartOk V,et al.Loss of mealinduced decrease in plasma ghrelin levels in patients with anorexia nervosa.J Clin Endocrinol Metab,2003,88:1678-1682.
  • 7Riis AL,Hansen TK,MOller N,et al.Hyperthyroidism is associated with suppressed circulating ghrelin levels.J Clin Endocrinol Metab,2003,88:853-857.
  • 8Flanagan DE,Evans ML,Moasod TP,et al.The influence of insulin on circulating ghrelin.Am J Physiol Endocrinol Metab,2003,284:E313-316.
  • 9Anderwald C,Brabant G,Bemroider E,et al.Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients.Diabetes,2003,52:1792-1798.
  • 10Kojima M,Hosoda H, Date Y,et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999,402:656-660.

共引文献18

同被引文献67

  • 1张江甲,张向东.甲亢患者血中微量元素的变化分析与探讨[J].基层医学论坛,2013,17(S1):47-48. 被引量:4
  • 2孙桂荣,田字彬,綦玉琴,李雨生,于素清,余云云.甲状腺功能与血清ghrelin和胖素-A水平的相关性[J].中华内科杂志,2005,44(3):217-218. 被引量:3
  • 3张宏,方佩华,郑凝,常宝成,赵伟,董如娇,王家驰.住院2型糖尿病患者甲状腺功能状态的分析[J].国际内分泌代谢杂志,2007,27(2):139-141. 被引量:79
  • 4叶任髙,陆再英.内科学[M].北京:人民卫生出版社,2004:247-260.
  • 5李卉.甲状腺功能亢进症病证结合诊疗方法及疗效观察[D].北京:北京中医药大学,2012.
  • 6Andras K, Rosie AZ, Heidi EW, et al. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism [ J ]. Neuron, 2012,73 ( 2 ) : 317332.
  • 7Ratliff J, Leite JO, Ogburn R, et al. Consuming eggs for breakfast influences plasma glucose and ghrelin, while reducing energy in- take during the next 24 hours in adult men[ J]. Nutr Res,2010,30 (2) :96-103.
  • 8WILLIAMS G R. Is prophylactic anti -resorptive therapy required inthyroid cancer patients receiving TSH - suppressive treatment withthyroxine? [J]. J Endocrinol Invest, 2014,37(8) : 775 -779.
  • 9GENG H, ZHANG X,WANG C,et al Even mildly elevated TSH isassociated with an atherogenic lipid profile in postmenopausal womenwith subclinical hypothyroidism [ J ]. Endocr Res,2014,40 ( 1 ):1 -7.
  • 10张兴渝,杨刚毅,李伶,李钶,阮华玲,李清明,阳皓,杨媚.甲状腺功能亢进症患者血浆Ghrelin水平的改变及其影响因素探讨[J].第三军医大学学报,2008,30(4):358-360. 被引量:8

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部